Cargando…

Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion

OBJECTIVE: The natural course of chronic carotid artery total occlusion (CTO) is poor. Previous reports suggested that carotid artery stenting (CAS) improves the clinical outcome of CTO. However, its long-term efficacy has not been established. This study assessed the mid- and long-term clinical out...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Shoko, Miki, Kazunori, Aizawa, Yuki, Karakama, Jun, Fujita, Kyohei, Maehara, Taketoshi, Nemoto, Shigeru, Sumita, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Neuroendovascular Therapy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370975/
https://www.ncbi.nlm.nih.gov/pubmed/37501906
http://dx.doi.org/10.5797/jnet.oa.2020-0057
_version_ 1785078054099353600
author Fujii, Shoko
Miki, Kazunori
Aizawa, Yuki
Karakama, Jun
Fujita, Kyohei
Maehara, Taketoshi
Nemoto, Shigeru
Sumita, Kazutaka
author_facet Fujii, Shoko
Miki, Kazunori
Aizawa, Yuki
Karakama, Jun
Fujita, Kyohei
Maehara, Taketoshi
Nemoto, Shigeru
Sumita, Kazutaka
author_sort Fujii, Shoko
collection PubMed
description OBJECTIVE: The natural course of chronic carotid artery total occlusion (CTO) is poor. Previous reports suggested that carotid artery stenting (CAS) improves the clinical outcome of CTO. However, its long-term efficacy has not been established. This study assessed the mid- and long-term clinical outcome of CAS for CTO. METHODS: We evaluated the clinical outcome of 15 patients who underwent CAS for CTO between September 2010 and October 2019. RESULTS: The technical success rate of recanalization was 93.3% (14 of 15 patients). Eight patients were treated using self-expanding stents, and six were treated using self-expanding coronary stents. Symptomatic procedure-related complications developed in two patients (13.3%). During the follow-up period (mean 34.9 months), symptomatic ipsilateral stroke was not noted. One patient (7.1%) developed asymptomatic re-occlusion, but stent patency was preserved in 13 patients (92.9%). CONCLUSION: CAS for CTO may be safe and feasible based on the mid- and long-term outcome.
format Online
Article
Text
id pubmed-10370975
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Society for Neuroendovascular Therapy
record_format MEDLINE/PubMed
spelling pubmed-103709752023-07-27 Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion Fujii, Shoko Miki, Kazunori Aizawa, Yuki Karakama, Jun Fujita, Kyohei Maehara, Taketoshi Nemoto, Shigeru Sumita, Kazutaka J Neuroendovasc Ther Original Article OBJECTIVE: The natural course of chronic carotid artery total occlusion (CTO) is poor. Previous reports suggested that carotid artery stenting (CAS) improves the clinical outcome of CTO. However, its long-term efficacy has not been established. This study assessed the mid- and long-term clinical outcome of CAS for CTO. METHODS: We evaluated the clinical outcome of 15 patients who underwent CAS for CTO between September 2010 and October 2019. RESULTS: The technical success rate of recanalization was 93.3% (14 of 15 patients). Eight patients were treated using self-expanding stents, and six were treated using self-expanding coronary stents. Symptomatic procedure-related complications developed in two patients (13.3%). During the follow-up period (mean 34.9 months), symptomatic ipsilateral stroke was not noted. One patient (7.1%) developed asymptomatic re-occlusion, but stent patency was preserved in 13 patients (92.9%). CONCLUSION: CAS for CTO may be safe and feasible based on the mid- and long-term outcome. The Japanese Society for Neuroendovascular Therapy 2020-12-02 2021 /pmc/articles/PMC10370975/ /pubmed/37501906 http://dx.doi.org/10.5797/jnet.oa.2020-0057 Text en ©2021 The Japanese Society for Neuroendovascular Therapy https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives International License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Fujii, Shoko
Miki, Kazunori
Aizawa, Yuki
Karakama, Jun
Fujita, Kyohei
Maehara, Taketoshi
Nemoto, Shigeru
Sumita, Kazutaka
Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion
title Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion
title_full Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion
title_fullStr Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion
title_full_unstemmed Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion
title_short Mid-/Long-Term Outcome of Neuroendovascular Treatment for Chronic Carotid Artery Total Occlusion
title_sort mid-/long-term outcome of neuroendovascular treatment for chronic carotid artery total occlusion
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370975/
https://www.ncbi.nlm.nih.gov/pubmed/37501906
http://dx.doi.org/10.5797/jnet.oa.2020-0057
work_keys_str_mv AT fujiishoko midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT mikikazunori midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT aizawayuki midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT karakamajun midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT fujitakyohei midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT maeharataketoshi midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT nemotoshigeru midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion
AT sumitakazutaka midlongtermoutcomeofneuroendovasculartreatmentforchroniccarotidarterytotalocclusion